Survival outcomes and efficacy of autologous CD19 chimeric antigen receptor-T cell therapy in the patient with diagnosed hematological malignancies: a systematic review and meta-analysis
Emmanuel Kwateng Drokow,1 Hafiz Abdul Waqas Ahmed,1 Cecilia Amponsem-Boateng,2 Gloria Selorm Akpabla,3 Juanjuan Song,1 Mingyue Shi,1 Kai Sun11Department of Hematology, Zhengzhou University People‘s Hospital & Henan Provincial People‘s Hospital Henan, Zhengzhou, People&...
Main Authors: | Drokow EK, Ahmed HAW, Amponsem-Boateng C, Akpabla GS, Song J, Shi M, Sun K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-05-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/survival-outcomes-and-efficacy-of-autologous-cd19-chimeric-antigen-rec-peer-reviewed-article-TCRM |
Similar Items
-
CAR T-cell therapy-transforming treatment of hematological malignancies
by: Shah Newaz Ahmed, et al.
Published: (2023-02-01) -
Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data
by: Gils Roex, et al.
Published: (2020-02-01) -
Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies
by: Eiji Kobayashi, et al.
Published: (2023-08-01) -
A critical assessment of dose effects of post‐thaw CD34 on autologous stem cell transplantation treatment of haematological malignancies
by: Gustavo de Carvalho Duarte, et al.
Published: (2023-05-01) -
Circulating microRNA as diagnostic biomarkers for haematological cancers: a systematic review and meta-analysis
by: Drokow EK, et al.
Published: (2019-05-01)